We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
-14.71%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$170M
AUM Growth
-$29.3M
Cap. Flow
+$3.67M
Cap. Flow %
2.16%
Top 10 Hldgs %
37.23%
Holding
516
New
389
Increased
31
Reduced
78
Closed

Top Sells

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$1.16M
2
LH icon
Labcorp
LH
+$655K
3
MSFT icon
Microsoft
MSFT
+$650K
4
ORCL icon
Oracle
ORCL
+$570K
5
JPM icon
JPMorgan Chase
JPM
+$551K

Sector Composition

Rank Sector Weight
1 Technology 24.94%
2 Consumer Staples 15.93%
3 Healthcare 14.92%
4 Financials 8.99%
5 Consumer Discretionary 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMLC icon
376
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$3K ﹤0.01%
+114
New +$2.89K
EWD icon
377
iShares MSCI Sweden ETF
EWD
$546M
$3K ﹤0.01%
+90
New +$3.18K
HMC icon
378
Honda
HMC
$39.1B
$3K ﹤0.01%
+122
New +$3.12K
HOG icon
379
Harley-Davidson
HOG
$2.58B
$3K ﹤0.01%
+100
New +$3.55K
KLAC icon
380
KLA
KLAC
$239B
$3K ﹤0.01%
+90
New +$3.03K
MCO icon
381
Moody's
MCO
$82.8B
$3K ﹤0.01%
+10
New +$2.99K
SRPT icon
382
Sarepta Therapeutics
SRPT
$1.57B
$3K ﹤0.01%
+40
New +$2.94K
SYY icon
383
Sysco
SYY
$40.8B
$3K ﹤0.01%
+34
New +$2.85K
VOO icon
384
Vanguard S&P 500 ETF
VOO
$979B
$3K ﹤0.01%
+10
New +$3.77K
HZNP
385
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3K ﹤0.01%
+33
New +$3.13K
CLPT icon
386
ClearPoint Neuro
CLPT
$448M
$2K ﹤0.01%
+134
New +$1.37K
CTSH icon
387
Cognizant
CTSH
$24.9B
$2K ﹤0.01%
+36
New +$2.75K
EA icon
388
Electronic Arts
EA
$53B
$2K ﹤0.01%
+18
New +$2.29K
EIX icon
389
Edison International
EIX
$28.2B
$2K ﹤0.01%
+36
New +$2.44K
EMBC icon
390
Embecta
EMBC
$216M
$2K ﹤0.01%
+86
New +$2.48K
FAST icon
391
Fastenal
FAST
$54.7B
$2K ﹤0.01%
+72
New +$1.94K
FTNT icon
392
Fortinet
FTNT
$119B
$2K ﹤0.01%
+40
New +$2.38K
ITRN icon
393
Ituran Location and Control
ITRN
$1.09B
$2K ﹤0.01%
+70
New +$1.64K
JAZZ icon
394
Jazz Pharmaceuticals
JAZZ
$15.9B
$2K ﹤0.01%
+12
New +$1.85K
KEYS icon
395
Keysight
KEYS
$54.5B
$2K ﹤0.01%
+12
New +$1.71K
LULU icon
396
lululemon athletica
LULU
$13.5B
$2K ﹤0.01%
+7
New +$2.24K
MNST icon
397
Monster Beverage
MNST
$94.3B
$2K ﹤0.01%
+46
New +$2K
MRVL icon
398
Marvell Technology
MRVL
$168B
$2K ﹤0.01%
+35
New +$1.98K
OSCR icon
399
Oscar Health
OSCR
$9.41B
$2K ﹤0.01%
+500
New +$3.18K
QGEN icon
400
Qiagen
QGEN
$8.54B
$2K ﹤0.01%
+44
New +$2.15K

Similar funds

Fairfield, Bush & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Fairfield, Bush & Co held 516 positions worth $170M, down 15% from $199M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Fairfield, Bush & Co's Q2 2022 filing shows 389 new, 31 increased and 78 reduced positions. Its largest new stake was Activision Blizzard: 9,723 shares worth $757K. The largest sale was Lowe's Companies, an estimated $1.16M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Fairfield, Bush & Co's largest Q2 2022 buy was Activision Blizzard: 9,723 shares worth $757K.
  • Fairfield, Bush & Co added most to CrowdStrike in Q2 2022, an estimated $642K increase.
  • Fairfield, Bush & Co's biggest Q2 2022 reduction was Lowe's Companies, cutting an estimated $1.16M.
  • Fairfield, Bush & Co's ten largest holdings make up 37% of its $170M portfolio in Q2 2022.
  • Fairfield, Bush & Co opened 389 new positions and closed 0 in Q2 2022.
  • Fairfield, Bush & Co's portfolio value fell 15% quarter-over-quarter to $170M.

Based on Fairfield, Bush & Co's 13F filing for Q2 2022, filed 9 Aug 2022.